Ads
related to: janssen pharmaceuticals stock price- Bull & Bear 3X ETFs
Fixed Income, International Equity
Market Cap And Sector Equity
- Pharma ETF
Direxion Pharma & Medical ETF
Daily Bull 3X Shares - PILL
- Healthcare ETF
Direxion Daily Healthcare ETF
Bull 3X Shares ETF - CURE
- ETF Line-up
View Direxion's Complete List of
Leveraged and Inverse ETFs.
- Bull & Bear 3X ETFs
Search results
FATE To End Janssen Deal and Prioritize Pipeline Development
Zacks via Yahoo Finance· 1 year agoFate Therapeutics, Inc. FATE announced that it has declined a proposal from Janssen Biotech, Inc., a...
Alkermes (ALKS) Gets Final Award in Janssen Arbitration, Ups View
Zacks via Yahoo Finance· 12 months agoAlkermes ALKS received a final award in its arbitration proceedings with Janssen Pharmaceuticals, a...
Here's How Much You'd Have If You Invested $1000 in Vertex Pharmaceuticals a Decade Ago
Zacks via Yahoo Finance· 5 months agoFor most investors, how much a stock's price changes over time is important. Not only can it impact...
The Unexpected Bad News For Novo's Ozempic In Biden's Drug Negotiations List
Investor's Business Daily· 9 months agoThere's a piece of bad news for Novo Nordisk's massively popular diabetes drug Ozempic in Medicare's...
Janssen Touts Encouraging Data From Two Ulcerative Colitis Treatments
Benzinga via Yahoo Finance· 2 years agoJanssen Pharmaceutical, a unit of Johnson & Johnson (NYSE: JNJ), announced data from an ongoing...
FDA Approves Johnson & Johnson's Ready To Use Cell Therapy For Multiple Myeloma
Benzinga via Yahoo Finance· 2 years agoThe FDA approved Janssen Pharmaceutical's, a unit of Johnson & Johnson (NYSE: JNJ), Tecvayli...
Janssen Scores Conditional Approval For Multiple Myeloma Treatment In Pretreated Patients
Benzinga via Yahoo Finance· 2 years agoJanssen Biotech Inc, a Johnson & Johnson (NYSE: JNJ) unit, received European conditional approval...
3 Pharmaceutical Stocks That Are Too Cheap to Ignore
Motley Fool· 9 months agoOn average, healthcare stocks haven't kept up with the gains made by the rest of the market this year. Viatris (NASDAQ: VTRS), GSK (NYSE: GSK), and...
Johnson & Johnson's HIV Vaccine Regimen Does Not Prevent Infection, Phase 3 Study Shows
Benzinga via Yahoo Finance· 1 year agoThe Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) announced the results of an...
Biotech Stock Roundup: HZNP Surges on AMGN Offer, TRDA Gains on VRTX Deal & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in the spotlight this week courtesy of acquisition news and strategic...